Eastman ChemicalEMN
EMN logo
Fair Value
US$81.13
Share price29 Jul
US$68.1416.0% undervalued intrinsic discount
Loading
1Y-10.11%
7D-1.23%

Commodity End Markets And Recycling Initiatives Will Shape Recovery Prospects Ahead

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
22 Aug 24
Updated
29 Jul 26
Views
490
Not Invested

Last Update 29 Jul 26

Fair value Decreased 3.79%

EMN: Recycling And Cost Discipline Will Support Resilient Earnings Through Commodity Headwinds

Analysts have trimmed their fair value and price targets for Eastman Chemical by roughly $3 to $4, to around the low $80s and down to the mid to high $70s on the Street, citing updated expectations for revenue growth, profit margins, P/E multiples, and sector wide pressures from commodity pricing, feedstock constraints, and changing views on the impact of Middle East developments.

Analyst Commentary

Recent research on Eastman Chemical highlights a mix of optimism and caution as analysts refresh their models ahead of upcoming results. Price targets have been reset in a relatively tight band, which keeps the focus on how execution, end market demand, and commodity inputs may affect valuation over the next few quarters.

Bullish Takeaways

  • Bullish analysts who raised their targets earlier in the year pointed to improving expectations for Eastman Chemical relative to prior views, which supported higher valuation ranges at that time.
  • Some optimistic research framed Eastman as better positioned than parts of the broader commodity chemicals group, which can matter for relative P/E support if earnings hold near current estimates.
  • Updated models ahead of the company’s Q2 report include scenarios where recent quarters track close to consensus, which helps limit immediate downside risk in valuation assumptions.
  • Street targets that remain in the upper $70s to mid $80s indicate that bullish analysts still see room for execution on growth and margin plans, even with sector headwinds in play.

Bearish Takeaways

  • Bearish analysts cutting price targets into the mid to high $70s point to pressure on commodity pricing, which can weigh on earnings power and compress the P/E multiple they are willing to apply.
  • Research tied to the Middle East conflict now assumes less benefit to basic chemicals than previously expected, which takes some support out of earlier valuation cases for Eastman Chemical.
  • Comments around MDI production constraints, force majeures, and shortages of carbon monoxide and chlorine feedstocks highlight operational risks that could affect volumes and costs.
  • Target reductions within the commodity chemicals group based on crude oil and chemical supply conditions, along with a weaker outlook for spreads, reflect concern that Street earnings estimates from Q3 onward may still be too high.

What’s in the News for Eastman Chemical

  • Eastman Chemical was removed from the Russell 1000 Value Defensive Index, according to a recent index constituent change.
  • Eastman Chemical was also removed from the Russell 1000 Defensive Index, reflecting another index-level adjustment.
  • From January 1, 2026 to March 31, 2026, Eastman Chemical reported no share repurchases under its ongoing buyback. The company has completed the repurchase of 32,948,297 shares, representing 25.51%, for US$3,155.42 million under the program announced on February 6, 2018.

Valuation Changes for Eastman Chemical

  • Fair Value has been trimmed from $84.33 to $81.13, a reduction of about 3.8% that lowers the central valuation anchor for Eastman Chemical.
  • Discount Rate has edged up from 8.29% to 8.34%, which slightly raises the hurdle that future cash flows need to clear in updated models.
  • Revenue Growth has been marked down from 3.52% to 3.29%, reflecting a more conservative view on dollar revenue expansion in coming periods.
  • Profit Margin has been nudged higher from 9.08% to 9.14%, which modestly adjusts modeled earnings quality for Eastman Chemical despite the lower growth rate.
  • Future P/E has been reduced from 13.78x to 13.28x, indicating a small reset in how much investors may be willing to pay for each dollar of expected earnings.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Expanding molecular recycling and specialty materials positions Eastman for growth as regulatory and consumer demand for sustainability strengthens across key markets.
  • Innovation, cost control, and supply chain reliability support margin expansion and predictable growth amid shifting environmental trends and global megatrends.
  • Trade tensions, weak demand, slow adoption of new products, regional concentration, and financial pressures threaten margins, growth prospects, and operational flexibility.

Catalysts

About Eastman Chemical
    Operates as a specialty materials company in the United States, China, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Eastman's ongoing success and expansion in molecular recycling/methanolysis (including debottlenecking at Kingsport and operational improvements) positions the company to capture premium pricing and win volume as regulations and customer demand for recycled content accelerate, particularly as mechanical recycling underperforms in key end markets-driving sustained revenue growth and EBITDA margin expansion.
  • Growth in sustainable, advanced materials (i.e., specialty plastics/polymers for packaging, automotive, and consumer goods), supported by stable long-term contracts with global consumer brands (e.g., Pepsi, Unilever), is likely to drive predictable volume growth and improved top-line stability as emerging market consumption rises and regulatory requirements for recycled content strengthen.
  • Accelerating adoption of lighter, more efficient materials for automotive (electrification, lightweighting) and electronics-sectors where Eastman's specialty polymers are critical-should result in robust demand, supporting revenue and margin growth in the company's high-value segments as global megatrends in mobility and electronics persist.
  • Implementation of cost reduction initiatives ($75M-$100M in ongoing savings), strategic asset optimization (such as the ethylene to propylene project), and disciplined portfolio management is likely to lead to improving net margins and higher ROIC, especially as end-market demand recovers and utilization rates normalize.
  • Continued differentiation through innovation leadership (advanced recycling and specialty materials) and supply chain reliability (North American manufacturing base) positions Eastman as a preferred partner amid tightening environmental regulation and supply chain localization, supporting margin resilience and reducing earnings volatility.
Eastman Chemical Earnings and Revenue Growth

Eastman Chemical Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Eastman Chemical's revenue will grow by 3.3% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 4.6% today to 9.1% in 3 years time.
  • Analysts expect earnings to reach $870.3 million (and earnings per share of $7.65) by about July 2029, up from $399.0 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.4x on those 2029 earnings, down from 19.5x today. This future PE is lower than the current PE for the US Chemicals industry at 24.8x.
  • Analysts expect the number of shares outstanding to decline by 0.42% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.34%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ongoing global trade tensions, high tariffs (15%–40%), and overcapacity/dumping from low-cost producers-particularly China-pose persistent risks to end-market demand, price realization, and market share, potentially leading to margin compression and suppressing revenue growth over the long term.
  • Uncertainty and volatility in customer demand, especially in key segments like consumer durables, automotive, and building & construction-driven by trade wars, inflation, and shifting inventory behaviors-may result in prolonged volume weakness and underutilization of assets, negatively impacting earnings and operating leverage.
  • Slower-than-expected adoption of innovative and recycled products (such as methanolysis-based Renew) due to customer economic caution, delayed project launches, and reliance on grant-related funding for expansion could limit top-line growth in high-value sustainable segments and stall improvements in EBITDA margins.
  • Elevated geographic dependence on US-based manufacturing and North American/European sales increases vulnerability to slowing regional GDP growth, retaliation in global trade disputes, and disruption of complex international supply chains, which could constrain revenue diversity and increase earnings volatility.
  • Overhang from recent capital-intensive investments, deferral of key growth projects, and the need for continued aggressive cost-cutting may restrict financial flexibility and cash flows, limiting capacity for R&D, innovation, and potential future shareholder returns, while higher interest expenses in a rising rate environment could erode net income.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $81.13 for Eastman Chemical based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $100.0, and the most bearish reporting a price target of just $69.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $9.5 billion, earnings will come to $870.3 million, and it would be trading on a PE ratio of 13.4x, assuming you use a discount rate of 8.3%.
  • Given the current share price of $68.14, the analyst price target of $81.13 is 16.0% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Eastman Chemical?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$69
FV
1.2% undervalued intrinsic discount
1.81%
Revenue growth p.a.
64
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$67.68
FV
0.7% overvalued intrinsic discount
9.52%
Revenue growth p.a.
65
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Fair Value vs Share Price

US$81.13
vs US$68.1416.0% undervalued intrinsic discount
PastFuture011b2015201820212024202620272029Revenue US$9.5bEarnings US$870.3m
3.3%
Revenue growth
9.1%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Eastman Chemical

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Undervalued established dividend payer.

Market capUS$7.7b
PB1.3x
Estimated Growth2.9%
Dividend Yield4.9%
Full analysis

CEO & management

Mark Costa
CEO
4.8yrs
CEO Tenure

Operates as a specialty materials company in the United States, China, and internationally.